Aytu Biopharma (AYTU) Net Margin (2013 - 2025)
Aytu Biopharma (AYTU) reported Net Margin of 0.41% for Q2 2025, up 890.0% year-over-year from 0.04% in Q2 2024, and up 39.98% quarter-over-quarter from 0.29% in Q1 2025.
Aytu Biopharma (AYTU) Net Margin (2013 - 2025) Analysis & Trends
Aytu Biopharma (AYTU) has 13 years of Net Margin data on file, last reported at 0.41% in Q2 2025.
- Net Margin for Q2 2025 came in at 0.41%, up 890.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.11% (up 114.0% YoY), and the FY2025 annual result was 0.93%, up 603.0% from the prior year.
- Net Margin climbed to 0.41% in Q2 2025 per AYTU's latest filing, from 0.29% in the prior quarter.
- Over five years, Net Margin peaked at 2.3% in Q3 2024 and troughed at 220.22% in Q1 2022.
- A 5-year average of 36.53% and a median of 8.4% in 2023 frame the typical range for Net Margin.
- The sharpest annual moves came in 2021 and 2023: Net Margin plunged 9534 bps in 2021, then surged 18855 bps in 2023.
- A 5-year view of Net Margin shows it stood at 49.94% in 2021, then surged by 49 bps to 25.47% in 2022, then surged by 82 bps to 4.48% in 2023, then jumped by 117 bps to 0.76% in 2024, then plunged by 46 bps to 0.41% in 2025.
- Business Quant data shows AYTU's Net Margin at 0.41% in Q2 2025, 0.29% in Q1 2025, and 0.76% in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 9.19% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 26.57% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 35.18% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 2.94% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 24.30% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 4.16% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -168.42% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 31.38% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -15.15% |
| 10 | Aytu Biopharma | 24.18 Mn | -2.54 Mn | 7.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.41% |
| Mar 31, 2025 | 0.29% |
| Dec 31, 2024 | 0.76% |
| Sep 30, 2024 | 2.30% |
| Jun 30, 2024 | -8.49% |
| Mar 31, 2024 | -4.27% |
| Dec 31, 2023 | -4.48% |
| Sep 30, 2023 | -3.63% |
| Jun 30, 2023 | -8.40% |
| Mar 31, 2023 | -31.67% |
| Dec 31, 2022 | -25.47% |
| Sep 30, 2022 | -2.53% |
| Jun 30, 2022 | -58.62% |
| Mar 31, 2022 | -220.22% |
| Dec 31, 2021 | -49.94% |
| Sep 30, 2021 | -127.19% |
| Jun 30, 2021 | -79.80% |
| Dec 31, 2020 | -62.88% |
| Sep 30, 2020 | -31.85% |
| Jun 30, 2020 | -54.24% |